Your session is about to expire
← Back to Search
Fast-Track Surgery for Hip and Knee Replacement
N/A
Waitlist Available
Research Sponsored by Maisonneuve-Rosemont Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patient needing a primary total hip or knee replacement (not associated with unusual treatment such as bone graft, osteotomy, revision implant, etc.)
Aged between 18 and 75 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion up to 2 years
Awards & highlights
Study Summary
This trial studies if fast-track surgery for hip and knee replacements is safe and beneficial for patients.
Who is the study for?
This trial is for adults aged 18-75 needing a primary total hip or knee replacement, without severe psychiatric issues, inflammatory joint diseases, obesity (BMI over 40), recent serious blood clots, or special perisurgical care. Participants must live near Maisonneuve-Rosemont Hospital and have support at home post-surgery.Check my eligibility
What is being tested?
The study tests a 'Fast-track' surgery program for patients undergoing total hip or knee replacements. It aims to evaluate how this approach affects recovery times and overall outcomes compared to traditional surgical methods.See study design
What are the potential side effects?
While the trial description does not specify side effects of the Fast-track program itself, typical risks may include pain at the surgery site, swelling, infection risk from surgery, and potential complications related to rapid mobilization.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I need a standard hip or knee replacement without special procedures.
Select...
I am between 18 and 75 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion up to 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion up to 2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of participants with adverse events
Secondary outcome measures
BMI
Blood loss in dressing before discharge in %
Blood pressure outcome at home 1 to 2 days after surgery
+69 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Fast-track total hip or knee arthroplastyExperimental Treatment1 Intervention
Be able to return patient home on the same day of a total hip or knee surgery.
Find a Location
Who is running the clinical trial?
Maisonneuve-Rosemont HospitalLead Sponsor
99 Previous Clinical Trials
36,173 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I need a standard hip or knee replacement without special procedures.I have a joint disease like rheumatoid arthritis or lupus.I am currently taking medication that affects CYP3A4 enzyme activity.I will need a long-term urinary catheter after surgery.I need long-term blood thinner medication.I have had a blood clot in my lungs or veins in the last year.My BMI is over 40.I have someone to support me before, during, and after my surgery for a week.I am currently on corticosteroids or have been in the past year.I have a condition that affects my nervous system or balance.I have a condition that increases my risk of bleeding during and after surgery.My kidney function is low, with a clearance rate under 30 ml/min.I am between 18 and 75 years old.I agree to use extra birth control for a month after taking Emend/Aprepitant before surgery.I need help moving around due to a problem not related to the joint getting replaced.I need special care during surgery, like ICU or dialysis.
Research Study Groups:
This trial has the following groups:- Group 1: Fast-track total hip or knee arthroplasty
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this research endeavor seek out participants aged 55 and over?
"This trial's enrollment criteria dictate that the minimum permissible age is 18 and no participant shall exceed 75 years old."
Answered by AI
For whom is this trial best suited?
"Participants eligible to join this clinical trial must have had orthopedic procedures and are between 18-75 years of age. This research requires a total of 150 volunteers."
Answered by AI
Are there any open spots remaining for enrollment in this trial?
"According to the information on clinicaltrials.gov, this specific trial is not currently seeking enrolment. Initially posted on November 1st 2016 and most recently updated on March 16th 2023, it does not appear that there is a call for patients at present; however, 17 other medical trials are open to participation now."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger